Engineering a mevalonate pathway in Escherichia coli for production of terpenoids

  title={Engineering a mevalonate pathway in Escherichia coli for production of terpenoids},
  author={Vincent J. J. Martin and Douglas J. Pitera and Sydnor T. Withers and Jack D. Newman and Jay D. Keasling},
  journal={Nature Biotechnology},
Isoprenoids are the most numerous and structurally diverse family of natural products. Terpenoids, a class of isoprenoids often isolated from plants, are used as commercial flavor and fragrance compounds and antimalarial or anticancer drugs. Because plant tissue extractions typically yield low terpenoid concentrations, we sought an alternative method to produce high-value terpenoid compounds, such as the antimalarial drug artemisinin, in a microbial host. We engineered the expression of a… 

Engineering Escherichia coli for production of functionalized terpenoids using plant P450s.

Two heterologous pathways for the biosynthesis of plant-derived terpenoid natural products are assembled, and the first examples of in vivo production of functionalized terpenoids in E. coli are presented using native plant P450s.

Construction and Optimization of Mevalonate Pathway for Production of Isoprenoids in Escherichia coli

It is demonstrated that balancing carbon flux through the engineered biosynthetic pathway is the key factor in optimization efforts towards high level production of isoprenoids.

Metabolic engineering of monoterpene synthesis in yeast

The results obtained with up to 5 mg/L geraniol suggest a major improvement compared with previous available expression systems like Escherichia coli or yeast strains with an unmodified ERG20 gene that respectively delivered amounts in the 10 and 500 µg/L range or even a previously characterized K197E mutation that delivered quantities in the 1  mg/Lrange.

Engineering the lactococcal mevalonate pathway for increased sesquiterpene production.

Isoprenoids are a large, diverse group of secondary metabolites which has recently raised a renewed research interest due to genetic engineering advances, allowing specific isoprenoids to be produced

Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae

The detailed description of various approaches used for engineering of methyl-d-erythritol-4-phosphate (MEP) and mevalonates (MVA) pathway for synthesizing isoprene units (C5) and ultimate production of diverse isoprenoids is provided.

Metabolic engineering of sesquiterpene metabolism in yeast

These yeast now provide a convenient format for investigating catalytic coupling between terpene synthases and hydroxylases, as well as a platform for the industrial production of high value, single‐entity and stereochemically unique terpenes.

Identification of Isopentenol Biosynthetic Genes from Bacillus subtilis by a Screening Method Based on Isoprenoid Precursor Toxicity

A novel method to clone terpene synthase genes is developed, which relies on the inherent toxicity of the prenyl diphosphate precursors to terpenes, which resulted in a reduced-growth phenotype in E. coli engineered to produce elevated levels of isopentenol.

Novel approaches and achievements in biosynthesis of functional isoprenoids in Escherichia coli

The introduction of heterologous mevalonate pathway-based genes into E. coli has been shown to improve the productivity of carotenoids or sesquiterpenes that are synthesized from farnesyl diphosphate and enables relevant researchers to efficiently analyze an isolated gene candidate for a terpene synthase (terpene cyclase).

Proteomic investigation of an Escherichia coli terpene production factory: prospects for metabolic engineering

This study demonstrates the importance of systems level –omic analyses in shedding light on bottlenecks that prevent commercially viable synthesis of highly beneficial natural products like terpene with E. coli as a biological chassis.



Engineered isoprenoid pathway enhances astaxanthin production in Escherichia coli.

Results show that the conversion from FPP to GGPP is the first bottleneck, followed sequentially by IPP isomerization and FPP synthesis, and removal of these bottlenecks results in an E. coli strain providing sufficient precursors for in vivo synthesis of isoprenoids.

Studies on the nonmevalonate terpene biosynthetic pathway: Metabolic role of IspH (LytB) protein

The transformation of exogenous 1-deoxy-d-xylulose into a 5:1 mixture of [U-13C5]isopentenyl diphosphate and dimethylallyl diph phosphate by an E. coli strain engineered for the expression of the ispH (lytB) gene in addition to recombinant xylB and ispCDEFG genes is described.

Metabolic engineering of the terpenoid biosynthetic pathway of Escherichia coli for production of the carotenoids β-carotene and zeaxanthin

Metabolic engineering of the early non-mevalonate terpenoid pathway of Escherichia coli was carried out to increase the supply of prenyl pyrophosphates as precursor for carotenoid production, with additive effect on ß-carotene and zeaxanthin production.

The in vivo synthesis of plant sesquiterpenes by Escherichia coli.

It is concluded that the limiting factor for sesquiterpene synthesis in E. coli is the poor expression of the cyclase enzyme and not supply of the FDP precursor.

Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production.

Given the low final densities of cells expressing dxs from IPTG-inducible promoters, the low lycopene production was probably due to the metabolic burden of plasmid maintenance and an excessive drain of central metabolic intermediates.

Metabolic engineering of carotenoid accumulation in Escherichia coli by modulation of the isoprenoid precursor pool with expression of deoxyxylulose phosphate synthase

Metabolic engineering of carbon flow from simple glucose metabolites to representatives of the largest class of natural products was demonstrated in this model system and rate-controlling enzymes encoded by the carotenogenic gene clusters are responsive to an increase in isoprenoid precursor pools.

Expression of an exogenous isopentenyl diphosphate isomerase gene enhances isoprenoid biosynthesis in Escherichia coli.

The results imply that IPP isomerase forms an influential step in isoprenoid biosynthesis of the prokaryote E. coli, with potential for the efficient production of industrially useful isopranoids by metabolic engineering.

Amorpha-4,11-diene synthase of Artemisia annua: cDNA isolation and bacterial expression of a terpene synthase involved in artemisinin biosynthesis.

The aims of this research were to molecularly clone and express amorpha-4,11-diene synthase for metabolic engineering and deduced amino acid sequence displayed 36% identity with 5-epi-aristolochene synthase of Nicotiana tabacum.

Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate: a novel system for the genetic analysis of the 2-C-methyl-d-erythritol 4-phosphate pathway for isoprenoid biosynthesis.

This system is used to show that the ygbP, ychB and ygbB genes are essential in E. coli and that the steps catalysed by the products of these genes belong to the trunk line of the MEP pathway.